rxstat › Shortages › Darunavir
Darunavir shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Darunavir products are in shortage in Canada (2 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 24, 2026.
In shortage since
Jun 9, 2026
Est. full return
Jul 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-DARUNAVIR
600MG · TABLET · APOTEX INC
DIN 02487241 · since Jun 9, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-DARUNAVIR
800MG · TABLET · APOTEX INC
DIN 02487268 · since Jun 30, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
ResolvedAURO-DARUNAVIR
600MG · TABLET · AURO PHARMA INC
DIN 02486121 · ended Jan 27, 2025 · Demand increase for the drug.
ResolvedAPO-DARUNAVIR
600MG · TABLET · APOTEX INC
DIN 02487241 · ended Oct 1, 2024 · Disruption of the manufacture of the drug.
ResolvedAURO-DARUNAVIR
800MG · TABLET · AURO PHARMA INC
DIN 02486148 · ended Jun 13, 2024 · Demand increase for the drug.
To be discontinuedPREZISTA
800MG · TABLET · JANSSEN INC
DIN 02393050
To be discontinuedPREZISTA
75MG · TABLET · JANSSEN INC
DIN 02338432
To be discontinuedPREZISTA
600MG · TABLET · JANSSEN INC
DIN 02324024
To be discontinuedPREZISTA
150MG · TABLET · JANSSEN INC
DIN 02369753
To be discontinuedPREZISTA
100MG · SUSPENSION · JANSSEN INC
DIN 02416530
ResolvedAURO-DARUNAVIR
600MG · TABLET · AURO PHARMA INC
DIN 02486121 · ended Jan 10, 2023 · Demand increase for the drug.
ResolvedAURO-DARUNAVIR
800MG · TABLET · AURO PHARMA INC
DIN 02486148 · ended Jun 30, 2022 · Demand increase for the drug.
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
Darunavir is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Darunavir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AE).
Recent changes
- Jul 9, 2026
Estimated end date pushed back: Jul 17, 2026 → Jul 24, 2026
Common questions
When will Darunavir be back in stock in Canada?
The latest manufacturer estimate is Jul 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Darunavir in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All direct acting antivirals shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.